المؤلفون: Moehler, M, Dvorkin, M, Boku, N, Ozguroglu, M, Ryu, M-H, Muntean, AS, Lonardi, S, Nechaeva, M, Bragagnoli, AC, Coskun, HS, Cubillo Gracian, A, Takano, T, Wong, R, Safran, H, Vaccaro, GM, Wainberg, ZA, Silver, MR, Xiong, H, Hong, J, Taieb, J, Bang, Y-J

مصطلحات الفهرس: Journal Article

URL: http://hdl.handle.net/11343/304515

المؤلفون: Moehler M; Johannes-Gutenberg University Clinic, Mainz, Germany., Xiao H; Bristol Myers Squibb, Princeton, NJ., Blum SI; Bristol Myers Squibb, Princeton, NJ., Elimova E; Princess Margaret Cancer Centre, Toronto, ON, Canada., Cella D; Northwestern University Feinberg School of Medicine, Chicago, IL., Shitara K; National Cancer Center Hospital East, Kashiwa, Japan., Ajani JA; The University of Texas MD Anderson Cancer Center, Houston, TX., Janjigian YY; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Garrido M; Clinica San Carlos de Apoquindo, Pontificia Universidad Católica, Santiago, Chile., Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China., Yamaguchi K; Cancer Institute Hospital of JFCR, Tokyo, Japan., Liu T; Zhongshan Hospital Fudan University, Shanghai, China., Schenker M; 2Department of Medical Oncology, Sfantul Nectarie Oncology Center, Dolj, Romania., Kowalyszyn R; 3Instituto Multidiciplinario de Oncología, Clinica Viedma SA, Viedma, Argentina., Bragagnoli AC; 4Fundacao Pio Xii Hosp Cancer De Barretos, Barretos, Brazil., Bruges R; 5Internal Medicine, Clinical Oncology, Instituto Nacional de Cancerología Empresa Social del Estado, Bogotá, Colombia., Montesarchio V; 6Ospedale V. Monaldi, Naples, Italy., Pazo-Cid R; 7Hospital Universitario Miguel Servet, Zaragoza, Spain., Hunter S; 8RTI Health Solutions, Research Triangle Park, NC., Davenport E; RTI Health Solutions, Research Triangle Park, NC., Wang J; RTI Health Solutions, Research Triangle Park, NC., Kondo K; Bristol Myers Squibb, Princeton, NJ., Li M; Bristol Myers Squibb, Princeton, NJ., Wyrwicz L; Klinika Onkologii i Radioterapii, Narodowy Instytut Onkologii, Warszawa, Poland.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 10; Vol. 41 (35), pp. 5388-5399. Date of Electronic Publication: 2023 Sep 15.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Adenocarcinoma*/drug therapy , Adenocarcinoma*/pathology, Humans ; Nivolumab/therapeutic use ; Quality of Life ; Esophagogastric Junction/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Pacheco ST; AC Camargo Cancer Center, São Paulo, Brazil., Donadio MD; AC Camargo Cancer Center, São Paulo, Brazil., Almeida F; AC Camargo Cancer Center, São Paulo, Brazil., O'Connor JM; Instituto Alexander Fleming, Buenos Aires, Argentina., de Miguel V; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Dioca M; Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina., Huaman J; Instituto Nacional Enfermidades Neoplasicas, Lima, Peru., Bragagnoli AC; Hospital de Amor, Barretos, Brazil., Weschenfelder RF; Hospital Moinho de Ventos, Porto Alegre, Brazil., Beltran PM; Instituto Nacional Enfermidades Neoplasicas, Lima, Peru., Riechelmann RP; AC Camargo Cancer Center, São Paulo, Brazil.

المصدر: Ecancermedicalscience [Ecancermedicalscience] 2023 Mar 20; Vol. 17, pp. 1523. Date of Electronic Publication: 2023 Mar 20 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ecancer Country of Publication: England NLM ID: 101392236 Publication Model: eCollection Cited Medium: Print ISSN: 1754-6605 (Print) Linking ISSN: 17546605 NLM ISO Abbreviation: Ecancermedicalscience Subsets: PubMed not MEDLINE

المؤلفون: Shitara K; National Cancer Center Hospital East, Kashiwa, Japan., Ajani JA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moehler M; Johannes-Gutenberg University Clinic, Mainz, Germany., Garrido M; Clinica San Carlos de Apoquindo, Pontificia Universidad Católica, Santiago, Chile., Gallardo C; Fundación Arturo López Pérez, Providencia, Chile., Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China., Yamaguchi K; The Cancer Institute Hospital of JFCR, Tokyo, Japan., Wyrwicz L; Klinika Onkologii i Radioterapii, Narodowy Instytut Onkologii, Warszawa, Poland., Skoczylas T; II Klinika Chirurgii Ogólnej, Gastroenterologicznej i Nowotworów Układu Pokarmowego, Medical University of Lublin, Lublin, Poland., Bragagnoli AC; Fundacao Pio Xii Hospital Cancer De Barretos, Barretos, Brazil., Liu T; Zhongshan Hospital Fudan University, Shanghai, China., Tehfe M; Oncology Center - Centre Hospitalier de l'Universite de Montreal, Montreal, Canada., Elimova E; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Bruges R; Instituto Nacional de Cancerologia E.S.E., Bogotá, Colombia., Zander T; University of Cologne, Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düesseldorf; Gastrointestinal Cancer Group Cologne (GCGC), Cologne, Germany., de Azevedo S; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Kowalyszyn R; Instituto Multidisciplinario de Oncologia, Clinica Viedma S.A., Viedma, Argentina., Pazo-Cid R; Hospital Universitario Miguel Servet, Zaragoza, Spain., Schenker M; SF Nectarie Oncology Center, Craiova, Romania., Cleary JM; Dana Farber Cancer Institute, Boston, MA, USA., Yanez P; Universidad de La Frontera, James Lind Cancer Research Center, Temuco, Chile., Feeney K; St John of God Murdoch Hospital, Murdoch, Australia., Karamouzis MV; Laiko General Hospital of Athens, Athens, Greece., Poulart V; Bristol Myers Squibb, Princeton, NJ, USA., Lei M; Bristol Myers Squibb, Princeton, NJ, USA., Xiao H; Bristol Myers Squibb, Princeton, NJ, USA., Kondo K; Bristol Myers Squibb, Princeton, NJ, USA., Li M; Bristol Myers Squibb, Princeton, NJ, USA., Janjigian YY; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. janjigiy@mskcc.org.

المصدر: Nature [Nature] 2022 Mar; Vol. 603 (7903), pp. 942-948. Date of Electronic Publication: 2022 Mar 23.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Esophageal Neoplasms*/drug therapy , Stomach Neoplasms*/drug therapy, B7-H1 Antigen ; Esophagogastric Junction ; Follow-Up Studies ; Humans ; Ipilimumab/adverse effects ; Ipilimumab/therapeutic use ; Nivolumab/adverse effects ; Nivolumab/therapeutic use

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Araujo CFM; Public Health Department, São Paulo State University (UNESP), Medical School, Botucatu, São Paulo, Brazil carolinafumico@gmail.com., Nunes LC; Public Health Department, São Paulo State University (UNESP), Medical School, Botucatu, São Paulo, Brazil., Murta-Nascimento C; Public Health Department, São Paulo State University (UNESP), Medical School, Botucatu, São Paulo, Brazil., Souza CP; Medial Oncology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Bragagnoli AC; Medial Oncology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Fukushima FB; Anaesthesiology Department, São Paulo State University (UNESP), Medical School, Botucatu, São Paulo, Brazil., Vidal EIO; Internal Medicine Department, São Paulo State University (UNESP), Medical School, Botucatu, São Paulo, Brazil.

المصدر: BMJ open [BMJ Open] 2021 Aug 09; Vol. 11 (8), pp. e044283. Date of Electronic Publication: 2021 Aug 09.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Metformin*/therapeutic use, Delivery of Health Care ; Female ; Humans ; Peer Review ; Randomized Controlled Trials as Topic ; Research Design ; Systematic Reviews as Topic

المؤلفون: Cunha Júnior AD; Department of Internal Medicine, Division of Oncology, University of Campinas (UNICAMP), Campinas 13083-970, São Paulo, Brazil., Bragagnoli AC; Division of Oncology, Hospital de Câncer de Barretos, Barretos 14784-400, São Paulo, Brazil., Costa FO; Department of Internal Medicine, Division of Oncology, University of Campinas (UNICAMP), Campinas 13083-970, São Paulo, Brazil., Carvalheira JBC; Department of Internal Medicine, Division of Oncology, University of Campinas (UNICAMP), Campinas 13083-970, São Paulo, Brazil. jbcc@unicamp.br.

المصدر: World journal of gastroenterology [World J Gastroenterol] 2021 May 07; Vol. 27 (17), pp. 1883-1904.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN: 2219-2840 (Electronic) Linking ISSN: 10079327 NLM ISO Abbreviation: World J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms* , Diabetes Mellitus, Type 2* , Metformin*/therapeutic use, Humans ; Hypoglycemic Agents/therapeutic use ; Insulin

المؤلفون: Moehler M; Department of Internal Medicine, Johannes-Gutenberg University, Mainz, Germany., Dvorkin M; Department of Oncology, Budgetary Healthcare Institution of Omsk Region Clinical Oncology Dispensary, Omsk, Russian Federation., Boku N; National Cancer Center Hospital, Tokyo, Japan., Özgüroğlu M; Clinical Trial Unit, Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Muntean AS; Department of Research, Oncology Institute Prof Dr Ion Chiricuţă, Cluj Napoca, Romania., Lonardi S; Dipartimento di Oncologia Clinica e Sperimentale, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Nechaeva M; Arkhangelsk Clinical Oncological Dispensary, State Budgetary Healthcare Institution of Arkhangelsk Region, Arkhangelsk, Russian Federation., Bragagnoli AC; Hospital de Câncer de Barretos-Fundação Pio XII, São Paulo, Brazil., Coşkun HS; Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey., Cubillo Gracian A; Hospital Universitario HM Sanchinarro, Madrid, Spain.; CEU Universidad San Pablo, Madrid, Spain., Takano T; Toranomon Hospital, Tokyo, Japan., Wong R; Eastern Health, Box Hill Hospital, Monash University, Melbourne, Victoria, Australia., Safran H; Rhode Island Hospital, Brown University, Providence, RI., Vaccaro GM; Oregon Health & Science University, Portland, OR., Wainberg ZA; Ronald Reagan University of California Los Angeles Medical Center, Santa Monica, CA., Silver MR; EMD Serono Research & Development Institute, Inc, Billerica, MA; an affiliate of Merck KGaA, Darmstadt, Germany., Xiong H; EMD Serono Research & Development Institute, Inc, Billerica, MA; an affiliate of Merck KGaA, Darmstadt, Germany., Hong J; EMD Serono Research & Development Institute, Inc, Billerica, MA; an affiliate of Merck KGaA, Darmstadt, Germany., Taieb J; Department of Gastroenterology and Digestive Oncology, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Bang YJ; Seoul National University Hospital, Seoul, Republic of Korea.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Mar 20; Vol. 39 (9), pp. 966-977. Date of Electronic Publication: 2020 Nov 16.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Induction Chemotherapy/*mortality , Maintenance Chemotherapy/*mortality , Stomach Neoplasms/*drug therapy, Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Capecitabine/administration & dosage ; Female ; Fluorouracil/administration & dosage ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Oxaliplatin/administration & dosage ; Prognosis ; Stomach Neoplasms/pathology ; Survival Rate

المؤلفون: Bragagnoli AC; Hospital de Câncer de Barretos, Barretos, SP, Brazil. aryscampos@yahoo.com.br., Araujo RLC; Hospital de Câncer de Barretos, Barretos, SP, Brazil.; Universidade Federal de São Paulo, São Paulo, SP, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Ferraz MW; Hospital de Câncer de Barretos, Barretos, SP, Brazil., Dos Santos LV; Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil., Abdalla KC; Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil., Comar F; Aliança Instituto de Oncologia, Brasília, DF, Brazil., Santos FA; Hospital de Câncer de Barretos, Barretos, SP, Brazil., Oliveira MA; Hospital de Câncer de Barretos, Barretos, SP, Brazil., Carvalheira JBC; Universidade Estadual de Campinas, Campinas, SP, Brazil., Cárcano FM; Hospital de Câncer de Barretos, Barretos, SP, Brazil., da Silveira Nogueira Lima JP; AC Camargo Cancer Center, São Paulo, SP, Brazil.

المصدر: British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (6), pp. 1072-1078. Date of Electronic Publication: 2021 Jan 04.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy , Neoplasm Recurrence, Local/*drug therapy, Adult ; Aged ; Colorectal Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Irinotecan/administration & dosage ; Male ; Metformin/administration & dosage ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Survival Rate ; Young Adult

المؤلفون: dos Santos LV; From aHemomed - Instituto de Oncologia e Hematologia & IEP Sao Lucas, Sao Paulo, and the bGastrointestinal Cancer Unit, Medical Oncology Department and cRadiology Department, Hospital de Câncer de Barretos, Barretos, Brazil., Lima JP, Abdalla KC, Bragagnoli AC, Santos FA, dos Anjos Jácome A, Porto FE

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2013 Oct 01; Vol. 11 (10), pp. 1187-91.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Benzamides/*adverse effects , Bone and Bones/*drug effects , Bone and Bones/*pathology , Edema/*chemically induced , Piperazines/*adverse effects , Protein Kinase Inhibitors/*adverse effects , Pyrimidines/*adverse effects, Antineoplastic Agents/therapeutic use ; Benzamides/therapeutic use ; Edema/diagnosis ; Gastrointestinal Stromal Tumors/complications ; Gastrointestinal Stromal Tumors/drug therapy ; Humans ; Imatinib Mesylate ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Piperazines/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Pyrimidines/therapeutic use ; Tomography, X-Ray Computed